Recent Updates
Recently added Catalysts
VNRX Positive Sentiment

NETs: Casting a new light on sepsis management – presentation

Monday, October 7, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Volition hosted a symposium at ESICM Lives 2024 focusing on the role of NETs in sepsis management. Chaired by Professor Djillali Annane, the session featured presentations from experts including Dr. Andrew Retter and Dr. Caroline Neumann. They discussed findings from significant studies that suggest the clinical utility of Nu.Q® NETs in enhancing sepsis treatment.
Price reaction · baseline $17.66 (2024-10-04 close) · hit pre-market · 6 other VNRX headline(s) in the window, move may be shared
day 0 close
-11.1%
day 1
-12.5%
day 3 · peak
-20.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • Presentation highlighted innovative approaches to sepsis management.
  • Experts shared findings from large, independent studies.
  • Potential clinical utility of Nu.Q® NETs was emphasized.

Full Press Release Details

Volition hosted a symposium at ESICM Lives 2024 titled NETs: Casting a new light on sepsis management. During the session, experts presented findings from large, independent studies regarding the potential clinical utility of Nu.Q® NETs to enhance sepsis management.
Chaired by Professor Djillali Annane, session speakers included Dr Andrew Retter, Dr Caroline Neumann of Jena University Hospital and Dr Terry Kelly.
You can download the symposium presentation below.

Related Articles

• Press Releases Data Showing the Prognostic Value of its Nu.Q® Cancer Test
• Poster & Publications Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states

Data Showing the Prognostic Value of its Nu.Q® Cancer Test

Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states

• Share
• Tweet
• Share on Facebook
• Share

Subscribe for Volition product updates .

Or, click here for Investor Updates and press releases .

" * " indicates required fields

Frequently Asked Questions

What was the focus of the Volition symposium?

The symposium focused on the role of NETs in sepsis management.

Who chaired the symposium session?

The session was chaired by Professor Djillali Annane.

What did the experts present at the symposium?

Experts presented findings from large, independent studies on Nu.Q® NETs.

What is the significance of Nu.Q® NETs?

Nu.Q® NETs may enhance clinical management of sepsis.

ShareAdd on Google
Tags: VNRX Viatris Investor Conferences Healthcare Volition Nu.Q® NETs sepsis ESICM Lives 2024 clinical utility
Last updated: Oct 7, 2024

Biotech snapshot

Cash runway
$3M liquidity · $2M/mo burn
~1 mo
High dilution risk